Bio

Technology companies from start-ups to Fortune 50 companies trust Mark Kass to structure, negotiate and document technology transactions, private equity financings, and mergers and acquisitions. Mark’s clients span the globe and operate throughout the technology ecosystem, including software, cybersecurity, fintech, cleantech, biotech, and medical devices.